Patient dies in Bristol Myers Squibb investigational CAR-T therapy trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Redesign Health and ARC Global Merge to Help Health Systems Shape the Future of Healthcare From Within
Redesign Health and Sheba Medical Center’s ARC Global also to acquire AVIA, with the three organizations bringing together…
Novo’s CagriSema shows 25% weight loss in women
Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women…
Launch price of new medicines dropped very slightly in 2025
Amid ongoing angst over prescription drug prices, a new analysis found the median net price for 202 newly…
New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year
In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…
Supplement sector rising, ‘safety needs to evolve with it’
Speaking during a webinar hosted by the International Alliance of Dietary and Food Supplement Associations (IADSA) last week,…
UnitedHealth Group (UNH) earnings Q3 2026
UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…
Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
USFDA’s gummy study, Australia’s rules on andrographis in regulatory round-up
The mature dietary supplement market has been drawing increasing scrutiny from regulators, inspectors and legacy supplement brands. (Colorsandia…
Probing the many benefits of GLP-1 receptor agonists
RESEARCH HIGHLIGHT 05 October 2026 Glucagon-like peptide 1 (GLP-1) receptor agonists are approved for the treatment of type…
Divergent trial results on cancer vaccines have field grappling with hard questions
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…
Eli Lilly’s Zepbound plus amylin drug led to major weight loss in mid-stage trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…